# A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

> **NCT03329911** · PHASE3 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 651 (actual)

## Conditions studied

- Non-squamous Non-small Cell Lung Cancer

## Interventions

- **DRUG:** EU Avastin®
- **DRUG:** BAT1706
- **DRUG:** Paclitaxel
- **DRUG:** carboplatin

## Key facts

- **NCT ID:** NCT03329911
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2019-11-05
- **Final completion:** 2021-05-27
- **Target enrollment:** 651 (ACTUAL)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03329911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03329911, "A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03329911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*